Controversial data on sarcosine as a promising biomarker for prostate cancer (PCa) detection are present. The objective was to clarify these discrepancies and reevaluate the potential value of ...

Diabetes mellitus has been linked with adverse prostate cancer (PCa) outcomes. However, role of hyperglycemia in PCa progression is unclear. We evaluated the link between hyperglycemia and PCa ...

Consensus on Prostate Cancer Treatment of Localized Disease With Very Low, Low, and Intermediate Risk: A Report From the First Prostate Cancer Consensus Conference for Developing Countries (PCCCDC) ...

Dutasteride (Avodart) treatment significantly reduces the relative risk of a prostate cancer (PCa) diagnosis in men with benign prostatic hyperplasia (BPH) undergoing screening with PSA tests and ...

The effect of ADT on objective cognitive performance and self-reported cognitive functionin men with prostate cancer. Background: REDUCE was a 4-year, randomized placebo (pbo) controlled study of ...

Exosomes participate in drug resistance, vascular remodeling, and antigen presentation. Exosomes not only impair the function of immune cells but also reshape the tumor microenvironment, thereby ...

VIENNA—Lower urinary tract symptoms (LUTS) in men may provide useful information about the risk of having prostate cancer (PCa) diagnosed, data from two studies presented at the 26 th Annual Congress ...

Researchers shed light on cutting-edge advances of AI in diagnosis, treatment, patient prognosis prediction, and molecular subtyping of PCa. Cancer is a significant global health issue affecting ...

Research conducted across multiple institutions, including the University of Southern California, University of Hawaii, and Harvard T.H. Chan School of Public Health reported that healthier lifestyle ...

New research has found that the risk for invasive prostate cancer increases significantly when patients have a family history of PBSIN along with invasive prostate cancer. Family history of prostatic ...